Reduced blood glucose levels by the combination of vadadustat in an elderly patient with chronic kidney disease who was receiving mitiglinide and sitagliptin: a case report

Ayumi Takakura, Toshinori Hirai, Naomi Hamaguchi, Rika Mukohara, Kazutaka Matsumoto, Yutaka Yano, Takuya Iwamoto · 2023

Read Reduced blood glucose levels by the combination of vadadustat in an elderly patient with chronic kidney disease who was receiving mitiglinide and sitagliptin: a case report by Ayumi Takakura, Toshinori Hirai, Naomi Hamaguchi, Rika Mukohara, Kazutaka Matsumoto, Yutaka Yano, Takuya Iwamoto (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10712123.txt.

Description

Ayumi Takakura and co-authors report a case where adding an anemia drug seems to have driven blood sugar too low in an older patient, in work from 2023. The patient, a man aged seventy-two, had diabetes and chronic kidney disease. He had taken two sugar drugs at steady doses for three years.

The new drug treats anemia from kidney disease. Twenty-three days after it began, his blood sugar fell to a low reading. Mean sugar levels across the day ran lower in the first weeks on the new drug than just before it. The team suspects the new drug changed how one sugar drug acts in the body. They urge care and close sugar checks when this mix is used.

Catalog record

CREATORAyumi Takakura, Toshinori Hirai, Naomi Hamaguchi, Rika Mukohara, Kazutaka Matsumoto, Yutaka Yano, Takuya Iwamoto
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE21 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10712123

Browse the full library · About the Tower of Babel